Quarterly Transactions Made in Gracell Biotechnologies Inc. (GRCL)
This table provides information about the institutional ownership of Gracell Biotechnologies Inc. (GRCL). The information is specifically focused on institutions that hold shares of Gracell Biotechnologies Inc..
Shares Purchased
Shares Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q1 2021 | 0 | 18,619,789 | 18,619,789 | — | 18,619,789 | |||
| Q2 2021 | 856,192 | 1,307,109 | 2,163,301 | 313,686 | 794,000 | 1,107,686 | 1,055,615 | |
| Q3 2021 | 11,863,442 | 1,907,476 | 13,770,918 | 618,523 | 407,041 | 1,025,564 | 12,745,354 | |
| Q4 2021 | 2,255,522 | 1,208,683 | 3,464,205 | 2,071,612 | 176,485 | 2,248,097 | 1,216,108 | |
| Q1 2022 | 1,217,624 | 5,143,364 | 6,360,988 | 3,421,128 | 4,314,920 | 7,736,048 | -1,375,060 | |
| Q2 2022 | 1,230,278 | 389,882 | 1,620,160 | 1,429,641 | 402,828 | 1,832,469 | -212,309 | |
| Q3 2022 | 58,363 | 478,250 | 536,613 | 645,357 | 87,529 | 732,886 | -196,273 | |
| Q4 2022 | 3,115,427 | 120,114 | 3,235,541 | 313,778 | 0 | 313,778 | 2,921,763 | |
| Q1 2023 | 3,669,970 | 2,605,690 | 6,275,660 | 2,978,675 | 0 | 2,978,675 | 3,296,985 | |
| Q2 2023 | 2,624,811 | 4,267,313 | 6,892,124 | 2,835,757 | 0 | 2,835,757 | 4,056,367 | |
| Q3 2023 | 9,205,383 | 9,775,011 | 18,980,394 | 2,936,151 | 0 | 2,936,151 | 16,044,243 | |
| Q4 2023 | 7,395,351 | 8,807,978 | 16,203,329 | 4,789,166 | 0 | 4,789,166 | 11,414,163 | |